PATENT CLAIM ANALYSIS

Application Number: 15923067
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "04400R"]

Abstract:
The present invention provides polynucleotide aptamers that selectively bind to and inhibit polymerization of sickle hemoglobin (HbS), pharmaceutical compositions comprising the same, methods of use for diagnostics and treatment of sickle cell disease, methods of use as capture reagents, and methods of rational drug design.

Claim (Index 61):
The method of  claim 54 , wherein the polynucleotide aptamer comprises a consensus sequence consisting of a nucleotide sequence selected from the group consisting of SEQ ID NOS:61, 62, 63, 64, and 65.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12858369', '11925645', '11925648', '12971695', '14418648']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7851270263718351
- 35 USC 102 Novelty (BERT): 0.514386761653666
- Combined Prediction Score: 0.7580529999000182
- Mean Citation Score: 253.822494
- Max Citation Score: 260.74802
- Similarity Product: 170.3566715316749

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test